Mobile

A Phase IV, Randomized, Double-Blind, Placebo-Controlled Two-Phase Crossover Study of the Metabolic Impact of Tenofovir Disoproxil Fumarate on HIV 1 Seronegative Healthy Adult Males

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-005083-25

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To assess the impact on insulin sensitivity (determined by peripheral glucose uptake using a euglycaemic clamp) of the administration of tenofovir DF compared with placebo for two weeks in HIV 1 seronegative healthy male volunteers.

Critère d'inclusion

  • Human Immunodeficiency Virus (HIV-1) Infection

Liens